A Biopharma Industry Perspective on the Current and Future State of Incentive Compensation

Trinity Life Sciences shares highlights from our latest TGaS Landscape report entitled, “Tenth Annual Incentive Compensation Landscape.” This highly anticipated report is based on interviews of 38 biopharmaceutical incentive compensation (IC) leaders who shared their experiences on IC planning.

The Tenth Annual edition is perhaps more critical than ever before as companies adapt IC approaches and plan amid COVID-19 challenges. From implementing COVID-specific Management by Objective (MBO) plans to design methodologies for projecting earnings for representatives, IC teams will have to continue to exercise creativity, discipline, and agility in order to effectively motivate the sales force.